v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Parent
Common stock shares
Additional Paid-in Capital
AOCI
Retained Earnings
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2024     71,783,000        
Beginning balance at Dec. 31, 2024 $ 3,681,422 $ 3,504,187 $ 73,413 $ 2,721,343 $ (49,218) $ 758,649 $ 177,235
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 113,870 113,870       113,870 (4,696)
Common stock issuances (in shares)     128,000        
Common stock issuances 5,543 5,543 $ 128 5,415      
Dividends declared (45,066) (45,066)       (45,066)  
Foreign currency exchange translation adjustment 104 84     84   20
Net actuarial gain arising during period, less amortization of unamortized benefit plan cost, net of tax and regulatory adjustment 268 268     268    
Ending balance (in shares) at Mar. 31, 2025     71,911,000        
Ending balance at Mar. 31, 2025 3,751,445 3,578,886 $ 73,541 2,726,758 (48,866) 827,453 172,559
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (40,154) (40,154)       (40,154) 2,528
Common stock issuances (in shares)     67,000        
Common stock issuances 7,083 7,083 $ 67 7,016      
Dividends declared (44,847) (44,847)       (44,847)  
Centuri stock sales 405,501 140,505   138,907 1,598   264,996
Foreign currency exchange translation adjustment 6,711 5,646     5,646   1,065
Net actuarial gain arising during period, less amortization of unamortized benefit plan cost, net of tax and regulatory adjustment 267 267     267    
Ending balance (in shares) at Jun. 30, 2025     71,978,000        
Ending balance at Jun. 30, 2025 $ 4,088,534 $ 3,647,386 $ 73,608 2,872,681 (41,355) 742,452 $ 441,148
Beginning balance (in shares) at Dec. 31, 2025 72,224,593   72,224,000        
Beginning balance at Dec. 31, 2025 $ 3,961,119   $ 73,854 2,898,965 (34,546) 1,022,846  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 138,374         138,374  
Common stock issuances (in shares)     149,000        
Common stock issuances 2,632   $ 149 2,483      
Dividends declared (893)         (893)  
Net actuarial gain arising during period, less amortization of unamortized benefit plan cost, net of tax and regulatory adjustment 446       446    
Ending balance (in shares) at Mar. 31, 2026     72,373,000        
Ending balance at Mar. 31, 2026 4,101,678   $ 74,003 2,901,448 (34,100) 1,160,327  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 42,122         42,122  
Common stock issuances (in shares)     71,000        
Common stock issuances 4,141   $ 71 4,070      
Dividends declared (46,820)         (46,820)  
Net actuarial gain arising during period, less amortization of unamortized benefit plan cost, net of tax and regulatory adjustment $ 24,169       24,169    
Ending balance (in shares) at Jun. 30, 2026 72,443,899   72,444,000        
Ending balance at Jun. 30, 2026 $ 4,125,290   $ 74,074 $ 2,905,518 $ (9,931) $ 1,155,629